Nasopharyngeal carcinoma survival by histology in endemic and non-endemic areas
Authors:
Open Access
- 12 November 2024
- journal article
- research article
- Published by Taylor & Francis in Annals of Medicine
- Vol. 56 (1) , 2425066
Abstract
To investigate the prognostic implications of histology among nasopharyngeal carcinoma (NPC) using the data from a Chinese cohort and the Surveillance, Epidemiology, and End Results (SEER) database. We included patients diagnosed with WHO II and III subtypes NPC from two independent cohorts (Xiamen [XM]-NPC cohort and SEER-NPC cohort). We identified 726 patients in the XM-NPC cohort and 1334 patients in the SEER cohort. In the XM-NPC cohort, 94 (12.9%) and 632 (87.1%) patients had WHO II and III subtypes, respectively. In the SEER-NPC cohort, 839 (62.9%) and 495 (37.1%) patients had WHO II and III subtypes, respectively. WHO II subtype patients had a higher smoking rate than the WHO III subtype (57.4% vs. 43.4%) in the XM-NPC cohort. There were no significant differences in age, gender, tumor stage, or nodal stage between the two subtypes in both cohorts. In the XM-NPC cohort, patients with the WHO II subtype had worse locoregional relapse-free survival (82.2% vs. 89.5%, p = 0.063), distant metastasis-free survival (72.4% vs. 85.9%, p = 0.028), disease-free survival (61.6% vs. 78.8%, p = 0.003), and overall survival (OS) (71.7% vs. 84.0%, p = 0.035) than those with WHO III subtype. In the SEER-NPC cohort, patients with the WHO II subtype had worse NPC-specific survival (81.1% vs. 89.4%, p < 0.001) and OS (71.6% vs. 78.8%, p < 0.001) than those with WHO III subtype. The multivariate analysis showed that histology was an independent prognostic factor associated with outcomes in both cohorts. Our study demonstrates the significant influence of histological subtypes on outcomes in NPC among various populations, highlighting substantial disparities between the WHO II and WHO III subtypes.Keywords
This publication has 44 references indexed in Scilit:
- Nasopharyngeal squamous cell carcinoma: a comparative analysis of keratinizing and nonkeratinizing subtypesInternational Forum of Allergy & Rhinology, 2014
- Early detection of nasopharyngeal carcinoma by plasma Epstein‐Barr virus DNA analysis in a surveillance programCancer, 2013
- The prognostic value of histological typing in nasopharyngeal carcinomaOral Oncology, 2012
- Expression of Excision Repair Cross-Complementation Group 1 as Predictive Marker for Nasopharyngeal Cancer Treated With Concurrent ChemoradiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- High expression of excision repair cross-complementation group1 protein predicts poor outcome in patients with nasopharyngeal cancerOral Oncology, 2010
- Incidence of nasopharyngeal carcinoma in Chinese immigrants, compared with Chinese in China and South East Asia: reviewThe Journal of Laryngology & Otology, 2009
- Epidemiology of nasopharyngeal carcinoma in the United States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histologyAnnals of Oncology, 2006
- Has survival improved for nasopharyngeal carcinoma in the United States?Otolaryngology–Head and Neck Surgery, 2005
- The significance of keratinizing squamous cell histology in chinese patients with nasopharyngeal carcinomaClinical Oncology, 1998
- Nasopharyngeal carcinoma: presenting symptoms and duration before diagnosis.1997